Breaking new ground in VGT development 🧬
High dose delivery has long been an industry bottleneck, but Fujifilm BSEL is leading the charge with a revolutionary continuous electroporation device. Historically hindered by low throughput and poor cell viability, this new technology promises to eliminate the need for chemically mediated transfection.
Set to debut in our Texas demo labs in early 2025, this device is poised to boost vector productivity, streamline manufacturing, and make VGTs more economically viable.
Read more here: https://lnkd.in/eFyTpTzW
Ubani Ferdinand Izugbara
2wFujifilm